The Michelson Prizes are focused on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery.

The Michelson Prizes are awarded annually to investigators under age 35 who are applying innovative research processes to advance the development of vaccines and immunotherapies for major global diseases. The selection committee will be looking to support research that is both highly innovative and has the potential for high impact.

Applicants from the full spectrum of related disciplines (e.g. clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, genomics, nanotechnology, etc...) are encouraged to apply.

Deadline for submission is October 31, 2019.